High levels of serum prostaglandin E2 in children with osteogenesis imperfecta are reduced by neridronate treatment.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | February 1, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |